Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line.
Ben Djemaa S, Hervé-Aubert K, Lajoie L, Falanga A, Galdiero S, Nedellec S, Soucé M, Munnier E, Chourpa I, David S, Allard-Vannier E. Ben Djemaa S, et al. Among authors: lajoie l. Biomacromolecules. 2019 Aug 12;20(8):3076-3086. doi: 10.1021/acs.biomac.9b00637. Epub 2019 Jul 30. Biomacromolecules. 2019. PMID: 31305991 Free article.
Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes.
Alric C, Hervé-Aubert K, Aubrey N, Melouk S, Lajoie L, Même W, Même S, Courbebaisse Y, Ignatova AA, Feofanov AV, Chourpa I, Allard-Vannier E. Alric C, et al. Among authors: lajoie l. J Nanobiotechnology. 2018 Feb 21;16(1):18. doi: 10.1186/s12951-018-0341-6. J Nanobiotechnology. 2018. PMID: 29466990 Free PMC article.
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer.
Desroys du Roure P, Lajoie L, Mallavialle A, Alcaraz LB, Mansouri H, Fenou L, Garambois V, Rubio L, David T, Coenon L, Boissière-Michot F, Chateau MC, Ngo G, Jarlier M, Villalba M, Martineau P, Laurent-Matha V, Roger P, Guiu S, Chardès T, Gros L, Liaudet-Coopman E. Desroys du Roure P, et al. Among authors: lajoie l. J Immunother Cancer. 2024 Jan 30;12(1):e007135. doi: 10.1136/jitc-2023-007135. J Immunother Cancer. 2024. PMID: 38290768 Free PMC article.
Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality.
Aubrey N, Gouilleux-Gruart V, Dhommée C, Mariot J, Boursin F, Albrecht N, Bergua C, Croix C, Gilotin M, Haudebourg E, Horiot C, Matthias L, Mouline C, Lajoie L, Munos A, Ferry G, Viaud-Massuard MC, Thibault G, Velge-Roussel F. Aubrey N, et al. Among authors: lajoie l. Antibodies (Basel). 2022 Aug 22;11(3):54. doi: 10.3390/antib11030054. Antibodies (Basel). 2022. PMID: 35997348 Free PMC article.
Adcitmer® , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinoma.
Esnault C, Leblond V, Martin C, Desgranges A, Baltus CB, Aubrey N, Lakhrif Z, Lajoie L, Lantier L, Clémenceau B, Sarma B, Schrama J, Houben R, Schrama D, Hesbacher S, Gouilleux-Gruart V, Feng Y, Dimitrov D, Guyétant S, Berthon P, Viaud-Massuard MC, Samimi M, Touzé A, Kervarrec T. Esnault C, et al. Among authors: lajoie l. Br J Dermatol. 2022 Feb;186(2):295-306. doi: 10.1111/bjd.20770. Epub 2021 Nov 2. Br J Dermatol. 2022. PMID: 34582565
Neutrophils can disarm NK cell response through cleavage of NKp46.
Valayer A, Brea D, Lajoie L, Avezard L, Combes-Soia L, Labas V, Korkmaz B, Thibault G, Baranek T, Si-Tahar M. Valayer A, et al. Among authors: lajoie l. J Leukoc Biol. 2017 Jan;101(1):253-259. doi: 10.1189/jlb.3AB0316-140RR. Epub 2016 Sep 1. J Leukoc Biol. 2017. PMID: 27587403
30 results